BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34200100)

  • 1. Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer.
    Dora D; Rivard C; Yu H; Pickard SL; Laszlo V; Harko T; Megyesfalvi Z; Dinya E; Gerdan C; Szegvari G; Hirsch FR; Dome B; Lohinai Z
    Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34200100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
    Dora D; Rivard C; Yu H; Bunn P; Suda K; Ren S; Lueke Pickard S; Laszlo V; Harko T; Megyesfalvi Z; Moldvay J; Hirsch FR; Dome B; Lohinai Z
    Mol Oncol; 2020 Sep; 14(9):1947-1965. PubMed ID: 32506804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases.
    Lohinai Z; Megyesfalvi Z; Suda K; Harko T; Ren S; Moldvay J; Laszlo V; Rivard C; Dome B; Hirsch FR
    Transl Lung Cancer Res; 2019 Dec; 8(6):938-950. PubMed ID: 32010572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
    Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
    Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
    La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
    Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages in Oral Carcinomas: Relationship with Cancer Stem Cell Markers and PD-L1 Expression.
    Suárez-Sánchez FJ; Lequerica-Fernández P; Suárez-Canto J; Rodrigo JP; Rodriguez-Santamarta T; Domínguez-Iglesias F; García-Pedrero JM; de Vicente JC
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated CD163
    Yoshida C; Kadota K; Yamada K; Fujimoto S; Ibuki E; Ishikawa R; Haba R; Yokomise H
    Lung Cancer; 2022 May; 167():34-40. PubMed ID: 35395482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness.
    Takeuchi H; Tanaka M; Tanaka A; Tsunemi A; Yamamoto H
    Oncol Lett; 2016 May; 11(5):3403-3408. PubMed ID: 27123124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
    Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
    Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Expression of immune checkpoints STING and MHCII in small cell lung cancer.
    Dora D; Rivard C; Yu H; Pickard SL; Laszlo V; Harko T; Megyesfalvi Z; Gerdan C; Dinya E; Hoetzenecker K; Hirsch FR; Lohinai Z; Dome B
    Cancer Immunol Immunother; 2023 Mar; 72(3):561-578. PubMed ID: 35978199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer.
    Sumitomo R; Hirai T; Fujita M; Murakami H; Otake Y; Huang CL
    Exp Ther Med; 2019 Dec; 18(6):4490-4498. PubMed ID: 31777551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.
    Cai L; Liu H; Huang F; Fujimoto J; Girard L; Chen J; Li Y; Zhang YA; Deb D; Stastny V; Pozo K; Kuo CS; Jia G; Yang C; Zou W; Alomar A; Huffman K; Papari-Zareei M; Yang L; Drapkin B; Akbay EA; Shames DS; Wistuba II; Wang T; Johnson JE; Xiao G; DeBerardinis RJ; Minna JD; Xie Y; Gazdar AF
    Commun Biol; 2021 Mar; 4(1):314. PubMed ID: 33750914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages-based immune-related risk score model for relapse prediction in stage I-III non-small cell lung cancer assessed by multiplex immunofluorescence.
    Wu XR; Peng HX; He M; Zhong R; Liu J; Wen YK; Li CC; Li JF; Xiong S; Yu T; Zheng HB; Chen YH; He JX; Liang WH; Cai XY
    Transl Lung Cancer Res; 2022 Apr; 11(4):523-542. PubMed ID: 35529784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
    Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
    Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
    Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.